Alzamend Neuro (ALZN) Share-based Compensation (IS) (2020 - 2022)
Alzamend Neuro's Share-based Compensation (IS) was $715,639 in fiscal Q2 2023 (quarter ended Oct 31, 2022), down 44.1% from $1.28 million a year earlier and down 17.5% from the prior quarter.
Alzamend Neuro (ALZN) Share-based Compensation (IS) (2020 - 2022) Analysis & Trends
On a trailing twelve-month basis, Alzamend Neuro's Share-based Compensation (IS) was $3.97 million through Oct 31, 2022, up 21.4% year-over-year; for FY2022 (ended Apr 30, 2022), it was $4.41 million, up 82.8% from FY2021.
- In earlier fiscal years, Share-based Compensation (IS) was $2.41 million in FY2021.
- The fiscal Q2 2023 figure marks the lowest quarterly Share-based Compensation (IS) since fiscal Q4 2021.
- Compared with a year earlier, Share-based Compensation (IS) was higher in four of the last five quarters, with growth averaging 36.2%.
- Per Business Quant data, ALZN's Share-based Compensation (IS) in the three fiscal quarters before Q2 2023 was $867,338 (Q1 2023), $1.26 million (Q4 2022) and $1.13 million (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Alzamend Neuro | 6.51 Mn | -8.95 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2022 | 715,639.00 |
| Jul 31, 2022 | 867,338.00 |
| Apr 30, 2022 | 1.26 Mn |
| Jan 31, 2022 | 1.13 Mn |
| Oct 31, 2021 | 1.28 Mn |
| Jul 31, 2021 | 739,622.00 |
| Apr 30, 2021 | 675,566.00 |
| Jan 31, 2021 | 575,127.00 |
| Jul 31, 2020 | 591,433.00 |
Alzamend Neuro Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();